Yartemlea

Narsoplimab · Omeros Corporation
PRESCRIPTION ONLY (USA)

Yartemlea ingredients

Active ingredientStrength
Narsoplimab370 mg/2mL

What Yartemlea is used for

Yartemlea is a specialist medicine. Its approved uses are listed on the official FDA label below.

Key facts

Brand
Yartemlea
Generic name
Narsoplimab
Made by
Omeros Corporation
Forms
Injection
Given
Intravenous
FDA approval
Biologic licence (BLA) BLA761152
On the US market since
2026

Official information

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Yartemlea?

Yartemlea (Narsoplimab) is a specialist medicine made by Omeros Corporation, approved by the US FDA.

What are the ingredients of Yartemlea?

Yartemlea contains Narsoplimab (370 mg/2mL).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.